1. Lemperle, G.: Immunization againstsarcoma 180 potentiated by RES stimulation.J. Reticuloendothel. Soc. 3, 385 (1966).
2. Ribi, E., McLaughlin, C. A., Cantrell, J. L., Brehmer, W., Azuma, I., Yamamura, Y., Stain, S. M., Hwang, K.M. and Toubiana, R.: Immunotherapy for tumors with microbial constituents or their synthetic analogues-review. In: The University of Texas System Cancer Center, M. D.Anderson Anderson Hospital and TumorInstitute (ed), “Immunotherapy of Human Cancer”, Raven Press, New York, NY 1978, p. 131.
3. Yamaguchi, T., Nakagawa, M., Hidaka, K., Yoshida, T., Sasaki, T., Akiyama, S. and Kuwano, M.: Potentiation by squalene of antitumor of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitrosourea in a murine tumor system.JPN. J. Cancer Res. (Gann) 76, 1021 (1985).
4. Yarkoni, E., Meltzer, M. S. and Rapp, H. J.; Tumor regression after intralesional injection of emulsified trehalose-6,6°-dimycolate (cord factor): efficacy increases with oil concentration.Int. J. Cancer 19, 818 (1977).
5. Ikekawa, T., Umeji, M., Manabe, T., Yonoma, S., Irinida, K., Mizunuma, H. and Ikekawa, N.: Studies on antitumor activity of squalene and its related compounds.Yakugaku Zasshi 106, 578 (1986).